Our Pricing

Wegovy vs Saxenda: Clinical Comparison for UK Patients

Published on: June 03, 2026

Choosing between wegovy vs saxenda uk comparison options requires understanding how semaglutide and liraglutide differ in clinical effectiveness, dosing frequency, and cost. At Cured Pharmacy, we provide transparent upfront pricing and expert guidance from UK-registered prescribers to help you make an informed decision about which weight loss injection may be right for you.

How Wegovy and Saxenda Work Differently

Both Wegovy (semaglutide) and Saxenda (liraglutide) are GLP-1 receptor agonists licensed by the MHRA for chronic weight management in the UK [1]. They work by mimicking the natural hormone GLP-1, which regulates appetite, slows gastric emptying, and helps control blood sugar levels. However, their molecular structures differ significantly, affecting how long they remain active in your body.

Wegovy is a once-weekly subcutaneous injection, whilst Saxenda requires daily administration [2]. This difference stems from semaglutide's longer half-life of approximately 7 days compared to liraglutide's 13 hours [1][2]. For many UK patients, the convenience of weekly dosing with Wegovy represents a significant practical advantage over daily injections, though individual preferences and clinical responses vary.

Clinical Trial Results: Weight Loss Outcomes

In the landmark STEP 1 trial, adults using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Approximately 50% of participants lost at least 15% of their initial body weight, and nearly one-third lost 20% or more. These results represent some of the most significant weight loss outcomes achieved with pharmacological intervention in clinical trials.

The SCALE Obesity and Prediabetes trial evaluated Saxenda over 56 weeks, with participants achieving an average weight loss of 8.0% compared to 2.6% with placebo [2]. Whilst this demonstrates meaningful clinical benefit, the magnitude of weight reduction was notably lower than observed with semaglutide. Approximately 33% of Saxenda users lost at least 10% of their body weight during the trial period.

It's important to note that individual responses vary considerably, and clinical trial averages don't predict your personal outcome. Your UK prescriber will consider your medical history, weight loss goals, and any contraindications when recommending the most appropriate treatment.

Real-World Effectiveness in UK Practice

Beyond controlled trial environments, UK prescribers have observed that patient adherence often differs between weekly and daily injection regimens. Whilst both medications can produce meaningful weight loss when used as prescribed alongside lifestyle modifications, the practical convenience of Wegovy's weekly dosing may support better long-term adherence for some patients. However, others prefer the flexibility of adjusting daily doses or find daily injections easier to incorporate into their routine.

Wegovy vs Saxenda UK Comparison: Dosing and Administration

Wegovy follows a structured dose escalation protocol over 16-20 weeks, starting at 0.25 mg weekly and gradually increasing to the maintenance dose of 2.4 mg weekly [3]. This gradual titration helps minimise gastrointestinal side effects whilst your body adjusts to the medication. The pre-filled FlexTouch pens are designed for subcutaneous injection into the abdomen, thigh, or upper arm.

Saxenda begins at 0.6 mg daily, increasing by 0.6 mg increments each week until reaching the maintenance dose of 3.0 mg daily [4]. The daily injection requirement means you'll use approximately 30 injections per month compared to 4-5 with Wegovy. Both medications should be stored in the refrigerator before first use, though in-use pens can be kept at room temperature for specified periods.

Your UK prescriber will provide detailed injection technique guidance during your clinical consultation. Proper injection site rotation and technique are essential for both medications to optimise absorption and minimise injection site reactions.

Practical Considerations for UK Patients

When comparing wegovy vs saxenda uk options, consider your lifestyle and preferences. Weekly injections may suit patients who travel frequently or prefer fewer injection events, whilst daily dosing offers more frequent opportunities to adjust timing around your schedule. Both require consistent use alongside reduced-calorie diet and increased physical activity for optimal results, as recommended by NICE guidelines for weight management [5].

Side Effects and Safety Profile Comparison

The most common side effects for both Wegovy and Saxenda are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal pain [1][2]. These effects typically occur during dose escalation and often diminish as your body adjusts. In clinical trials, nausea affected approximately 44% of Wegovy users and 39% of Saxenda users, though most cases were mild to moderate in severity.

Both medications carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though the relevance to humans remains uncertain [3][4]. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will screen for these contraindications during your clinical assessment.

Serious but less common risks include pancreatitis, gallbladder disease, and acute kidney injury, particularly in patients who experience severe vomiting or diarrhoea leading to dehydration [5]. If you experience persistent severe abdominal pain, you should contact your healthcare provider immediately. Both medications may also affect heart rate slightly, and regular monitoring is recommended for patients with cardiovascular conditions.

Transparent Pricing: No Hidden Consultation Fees

At Cured Pharmacy, Wegovy starts from £79.00 with completely transparent pricing displayed before your free clinical consultation [6]. Unlike some UK pharmacy services that add consultation fees, prescription charges, or delivery costs at checkout, our upfront pricing model ensures you know exactly what you'll pay from the start. This commitment to transparency reflects our superintendent pharmacist Tarun Kumar's dedication to accessible, honest healthcare.

The total cost of your weight loss treatment depends on your prescribed dose and treatment duration, which your UK prescriber determines based on your clinical assessment and response to therapy. Both medications require ongoing prescription renewal through regular clinical reviews to monitor your progress, adjust dosing if needed, and ensure continued safety and appropriateness of treatment.

We guarantee the lowest prices in the UK for genuine, MHRA-licensed weight loss medications. All prescriptions are fulfilled by our GPhC-registered pharmacy (9012511) with discreet packaging and reliable delivery. There are no hidden fees, membership charges, or surprise costs — just transparent, competitive pricing for quality pharmaceutical care.

What's Included in Your Treatment Package

Your treatment includes a comprehensive online clinical assessment completed in under 3 minutes, review and prescribing by a UK-registered prescriber, dispensing by our qualified pharmacy team, and discreet home delivery. Follow-up consultations for prescription renewals are also provided at no additional consultation fee, ensuring continuity of care throughout your weight loss journey.

Starting Your Weight Loss Treatment at Cured Pharmacy

Beginning treatment is straightforward: complete our online clinical questionnaire, which takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your assessment, typically within 24 hours, and determines whether Wegovy, Saxenda, or an alternative treatment is clinically appropriate for you.

If approved, your prescription is sent to our GPhC-registered pharmacy where our team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), dispenses your medication. We use 100% discreet packaging for all deliveries, with no external indication of contents. Most orders are dispatched within 1-2 working days via tracked courier.

Weight loss medications work best as part of a comprehensive approach including dietary changes and increased physical activity. Your prescriber may provide guidance on lifestyle modifications, and we encourage working with your NHS GP or practice nurse for ongoing weight management support. Regular monitoring of your progress, side effects, and overall health is essential for safe, effective treatment.

If you have questions about which medication may be right for you, our pharmacy team is available on (+44) 116 4646009 during business hours. However, only a qualified prescriber can determine clinical suitability through a proper assessment — we cannot provide prescribing advice over the phone.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Novo Nordisk. (2023). Saxenda 6 mg/ml Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/2313 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Obesity: Identification, Assessment and Management (CG189). NICE Guidelines. Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide (Wegovy) and Liraglutide (Saxenda): Drug Safety Update. GOV.UK. Retrieved from https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.